Inhibrx Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $146.5M
Liabilities Breakdown FY2025
Total Liabilities: $138.5M
Asset Breakdown
Total Assets: $146.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $124.2M | 84.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.7M | 2.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $18.5M | 12.6% |
Liabilities Breakdown
Total Liabilities: $138.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.9M | 4.3% |
| Long-Term Debt | $100.6M | 72.6% |
| Other Liabilities | $32.0M | 23.1% |